RxSight Inc (NASDAQ: RXST) on Friday, plunged -3.10% from the previous trading day, before settling in for the closing price of $34.50. Within the past 52 weeks, RXST’s price has moved between $33.03 and $66.54.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 201.89% over the past five years. The company achieved an average annual earnings per share of 48.81%. With a float of $38.27 million, this company’s outstanding shares have now reached $40.25 million.
Let’s look at the performance matrix of the company that is accounted for 374 employees. In terms of profitability, gross margin is 63.45%, operating margin of -28.24%, and the pretax margin is -22.17%.
RxSight Inc (RXST) Insider Updates
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of RxSight Inc is 5.05%, while institutional ownership is 84.54%. The most recent insider transaction that took place on Nov 29 ’24, was worth 143,078. In this transaction an insider of this company sold 3,105 shares at a rate of $46.08, taking the stock ownership to the 42,246 shares. Before that another transaction happened on Nov 29 ’24, when Company’s Officer proposed sale 3,105 for $46.08, making the entire transaction worth $143,078.
RxSight Inc (RXST) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 48.81% per share during the next fiscal year.
RxSight Inc (NASDAQ: RXST) Trading Performance Indicators
RxSight Inc (RXST) is currently performing well based on its current performance indicators. A quick ratio of 11.71 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.82, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of RxSight Inc (RXST)
RxSight Inc (NASDAQ: RXST) saw its 5-day average volume 0.65 million, a positive change from its year-to-date volume of 0.6 million. As of the previous 9 days, the stock’s Stochastic %D was 28.42%. Additionally, its Average True Range was 1.77.
During the past 100 days, RxSight Inc’s (RXST) raw stochastic average was set at 2.29%, which indicates a significant decrease from 10.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.85% in the past 14 days, which was higher than the 44.07% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $42.13, while its 200-day Moving Average is $50.63. Nevertheless, the first resistance level for the watch stands at $34.34 in the near term. At $35.26, the stock is likely to face the second major resistance level. The third major resistance level sits at $36.00. If the price goes on to break the first support level at $32.68, it is likely to go to the next support level at $31.94. Assuming the price breaks the second support level, the third support level stands at $31.02.
RxSight Inc (NASDAQ: RXST) Key Stats
Market capitalization of the company is 1.35 billion based on 40,304K outstanding shares. Right now, sales total 89,080 K and income totals -48,610 K. The company made 35,310 K in profit during its latest quarter, and -6,340 K in sales during its previous quarter.
